Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Moreno

Showing results (51-60 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancerGilles Vassal, Raphaël Rousseau, Patricia Blanc, et al.
Leukemia Research|September 8, 2019
High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experienceFernando Carceller, Steffen G Hirsch, Komel Khabra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2020
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced TumorsDavid Ruano, José A López-Martín, Lucas Moreno, et al.
Cancers|February 11, 2023
Targeting the Hedgehog Pathway in RhabdomyosarcomaPatricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, et al.
Cancers|March 29, 2023
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the AmpliconGuillem Pons, Gabriel Gallo-Oller, Natalia Navarro, et al.
Allergologia Et Immunopathologia|March 15, 2025
A Delphi consensus on diagnosis, management, and treatment with allergen immunotherapy of polysensitized children in Spain: CAPP study, Part 2Ana I Tabar, Helena Larramona Cabrera, Cristina Rivas-Juesas, et al.
British Journal of Cancer|October 5, 2016
Factors associated with recurrence and survival length following relapse in patients with neuroblastomaNermine O Basta, Gail C Halliday, Guy Makin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2026
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) ConsortiumUri Ilan, Alba Rubio-San-Simón, Natasha van Eijkelenburg, et al.
International Journal of Molecular Sciences|December 10, 2021
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In VivoIrina Giralt, Gabriel Gallo-Oller, Natalia Navarro, et al.
Nature Reviews. Clinical Oncology|May 17, 2017
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspectiveLucas Moreno, Andrew D J Pearson, Xavier Paoletti, et al.
Pageof 13

Showing results (51-60 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|December 2, 2014
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancerGilles Vassal, Raphaël Rousseau, Patricia Blanc, et al.
Leukemia Research|September 8, 2019
High-dose etoposide and cyclophosphamide in adults and children with primary refractory and multiply relapsed acute leukaemias: The Royal Marsden experienceFernando Carceller, Steffen G Hirsch, Komel Khabra, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 14, 2020
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced TumorsDavid Ruano, José A López-Martín, Lucas Moreno, et al.
Cancers|February 11, 2023
Targeting the Hedgehog Pathway in RhabdomyosarcomaPatricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, et al.
Cancers|March 29, 2023
Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the AmpliconGuillem Pons, Gabriel Gallo-Oller, Natalia Navarro, et al.
Allergologia Et Immunopathologia|March 15, 2025
A Delphi consensus on diagnosis, management, and treatment with allergen immunotherapy of polysensitized children in Spain: CAPP study, Part 2Ana I Tabar, Helena Larramona Cabrera, Cristina Rivas-Juesas, et al.
British Journal of Cancer|October 5, 2016
Factors associated with recurrence and survival length following relapse in patients with neuroblastomaNermine O Basta, Gail C Halliday, Guy Makin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2026
Eligibility criteria in pediatric oncology phase I and II clinical trials: Analysis and recommendations for standardization from the Innovative Therapies for Children and Adolescents with Cancer (ITCC) ConsortiumUri Ilan, Alba Rubio-San-Simón, Natasha van Eijkelenburg, et al.
International Journal of Molecular Sciences|December 10, 2021
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In VivoIrina Giralt, Gabriel Gallo-Oller, Natalia Navarro, et al.
Nature Reviews. Clinical Oncology|May 17, 2017
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspectiveLucas Moreno, Andrew D J Pearson, Xavier Paoletti, et al.
Pageof 13